From the American Academy of Ophthalmology
News from the FSO
From the American Academy of Ophthalmology
First-year results of two phase 3 studies comparing intravitreal aflibercept, monthly or every two months, with monthly ranibizumab show that aflibercept can potentially decrease the treatment and compliance burden of anti-VEGF treatment. Results show aflibercept dosed monthly or every two months after three initial monthly doses resulted in similar visual and anatomic outcomes as ranibizumab dosed monthly, and with a similar safety and tolerability profile. Ophthalmology, December 2012
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
From the American Academy of Ophthalmology
The Obama Administration last week released a proposed rule to clarify that medically necessary services for Medicaid-eligible individuals who are 21 or younger – including pediatric vision care – must meet Medicaid Early Periodic Screening, Diagnosis, and Treatment program requirements.
The rule establishes that regardless of coverage set for plans participating in state insurance exchanges initiated by the health care reform law, EPSDT program requirements must be met for these Medicaid-eligible individuals.
(Jacksonville, FL)—In an effort to protect Florida's eye patients and ensure the highest quality of ocular care available by properly trained licensed medical physicians, Rep. Jeanette M. Nunez, R-Miami, has filed a bill (HB 443) known as the Eye Patient Protection Act of 2013. Sen. Rob Bradley-R, Orange Park, is sponsoring a companion bill in the Senate. Lauded by the Florida Society of Ophthalmology (FSO) as an unprecedented measure to protect eye patients, the bill outlines five items that would protect consumers (patients) when it comes to eye care. Specifically the bill: